Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with a-Reference-Cited by-同舟云学术

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with a

Published:2001-06 Issue:4 Volume:113 Page:1060-1071
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Kröger Nicolaus,Zabelina Tatjana,Krüger William,Renges Helmut,Stute Norbert,Schrum Johanna,Kabisch Hartmut,Schafhausen Philippe,Jaburg Nicole,Löliger Cornelius,Schäfer Peter,Hinke Axel,Zander Axel R.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02849.x/fullpdf

Reference40 articles.

1. Effect of HLA incompatibility on graft versus host disease, relapse, and survival after marrow transplantation for patients with leukemia and lymphoma;Anasetti;Human Immunology,1990

2. CMV antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell number with transplant-related mortality;Bacigalupo;Bone Marrow Transplantation,1995

3. Potent effect of ATG as part of the conditioning in matched unrelated donor (MUD) transplantation;Baurmann;Blood,1998

4. Marrow transplantation from related donors other than HLA-identical siblings;Beatty;New England Journal of Medicine,1985

5. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation;Boeckh;Blood,1996

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML);BMC Immunology;2023-06-20

2. Research Progress on Predisposing Factors and Prevention of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation;Advances in Clinical Medicine;2023

3. Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence;Virology Journal;2022-09-29

4. Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil;PLOS ONE;2022-07-29

5. Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2022-07-13